← Leaderboards
Nikhil Wagle
Dana-Farber Cancer Inst
$3,389,877
Attributed
$5,267,633
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,643,172 · 6
By mechanism
U2C$8,301,352 · 2
U01$2,816,634 · 1
U54$361,153 · 2
P50$164,033 · 1
Top collaborators
- Katherine A Janeway2 shared
- Pasi A Janne2 shared
- Eliezer M Van Allen2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Jennifer W Mack$13,071,700
- Eliezer M Van Allen$14,227,870
- Kimmie Ng$5,327,974
- Qianben Wang$7,988,225
- A. Heather Eliassen$24,939,674
Others in their field
Top investigators on “Dana-Farber Cancer Institute”
- Peter J O'Dwyer · University Of Pennsylvania$82,012,605
- Robert J Gray · Dana-Farber Cancer Institute$36,664,819
- Joseph Avruch · Massachusetts General Hospital$28,477,304
- Jerome Ritz · Cornell University$27,613,329
- Edward J Benz · Dana-Farber Cancer Institute$27,533,423
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
Research focus
Dana-Farber Cancer InstituteGenomicsResearch PersonnelProgramsGenomic DataClinical TrialsTechnologyCancer BiologyConsentTumorMalignant NeoplasmsComputational BiologyCaringTumor TissueAnticancer ResearchGenomeClinical ResearchTargeted TreatmentMemberMorbidity - Disease RateInstitutionChildAdultComputer Analysis
Grant awards (15)
Administrative Core$398,499
U2C · FY2025 · CA · contact PI
Genomics Core$294,732
U54 · FY2025 · CA · contact PI
Administrative Core$355,636
U2C · FY2024 · CA · contact PI
Genomics Core$7,035
U54 · FY2024 · CA · contact PI
Administrative Core$307,600
U2C · FY2023 · CA · contact PI
Developmental Research Program$164,033
P50 · FY2023 · CA · contact PI
Genomics Core$21,338
U54 · FY2023 · CA · contact PI
Genomics Core$16,083
U54 · FY2022 · CA · contact PI
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$3,210,930
U2C · FY2021 · CA · contact PI
Administrative Core$576,039
U2C · FY2021 · CA · contact PI
Genomics Core$21,965
U54 · FY2021 · CA · contact PI
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$3,164,609
U2C · FY2020 · CA · contact PI
Administrative Core$288,039
U2C · FY2020 · CA · contact PI
The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients$1,408,317
U01 · FY2016 · HG
The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients$1,408,317
U01 · FY2015 · HG